Acute Interstitial Nephritis Associated with the Use of Mesalazine in Inflammatory Bowel Disease
2002; Volume: 92; Issue: 1 Linguagem: Inglês
10.1159/000064461
ISSN2235-3186
AutoresNiels Erik Frandsen, Søren Saugmann, Niels Marcussen,
Tópico(s)Inflammatory Bowel Disease
Resumo<i>Background:</i> In the last 10 years several reports have linked oral 5-aminosalicylic acid (5-ASA) therapy to acute and chronic tubulointerstitial nephritis, but to our knowledge only 2 patients have been reported with terminal end-stage renal disease due to mesalazine (5-ASA). After 1 year of treatment with 5-ASA annual monitoring of serum creatinine is recommended. <i>Results:</i> We report the development of end-stage renal disease in a patient 10 months after the last assessment of serum creatinine, which was normal at 71 µmol/l. <i>Conclusion:</i> Because of this dangerous side effect, we would like to recommend 6-monthly assessment of renal function.
Referência(s)